Cardiff Oncology, Inc.

( )
CRDF PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Services » Medical Or Nursing Services
NVTAInvitae Corp. 0.67%49.701.4%$134.24m
GHGuardant Health, Inc. 1.34%121.250.0%$128.93m
DVADaVita, Inc. 0.44%108.913.5%$97.85m
SDCSmileDirectClub, Inc. 0.34%11.980.0%$88.76m
FLGTFulgent Genetics, Inc. -0.21%46.980.7%$80.54m
ONEM1Life Healthcare, Inc. -0.06%34.800.0%$69.48m
NTRANatera, Inc. 0.00%90.761.2%$57.17m
MDMEDNAX, Inc. -0.05%21.0111.1%$46.42m
CHEChemed Corp. 0.04%476.8710.1%$43.18m
AMEDAmedisys, Inc. 0.00%247.4311.3%$38.29m
LHCGLHC Group, Inc. 0.00%196.142.9%$37.01m
NEONeoGenomics, Inc. 0.00%47.265.7%$28.68m
OTRKOntrak, Inc. 0.33%51.500.0%$23.95m
ACHCAcadia Healthcare Co., Inc. 0.00%42.2827.1%$23.33m
CRDFCardiff Oncology, Inc. -0.05%22.310.0%$19.47m

Company Profile

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.